Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany : : a multicenter feasibility and acceptance survey

Abstract: Background
Li‐Fraumeni syndrome (LFS) is a high‐risk cancer predisposition syndrome caused by pathogenic germline variants of TP53. Cancer surveillance has noted a significant survival advantage in individuals with LFS; however, little is known about the feasibility, acceptance, and psychosocial effects of such a program.

Methods
Pathogenic TP53 germline variant carriers completed a 7‐part questionnaire evaluating sociodemographics, cancer history, surveillance participation, reasons for nonadherence, worries, and distress adapted from the Cancer Worry Scale. Counselees' common concerns and suggestions were assessed in MAXQDA Analytics Pro 12.

Results
Forty‐nine participants (46 females and 3 males), aged 40.0 ± 12.6 years, formed the study population; 43 (88%) had a personal cancer history (including multiple cancers in 10 [20%]). Forty‐three individuals participated (88%) in surveillance during the study or formerly. Willingness to undergo surveillance was influenced by satisfaction with genetic testing and counseling (P = .019 [Fisher‐Yates test]) but not by sociodemographics, cancer history, or distress level. Almost one‐third of the participants reported logistical difficulties in implementing surveillance because of the high frequency of medical visits, scheduling difficulties, and the travel distance to their surveillance providers. Self‐reported distress and perceived emotional burden for family members and partners were moderate (median for self‐reported distress, 3.3; median for perceived emotional burden, 3.0). For both, the interquartile range was moderate to very high (2.7‐3.7 and 3.0‐3.7, respectively).

Conclusions
Individuals with LFS require efficient counseling as well as an accessible, well‐organized, interdisciplinary, standardized surveillance program to increase adherence and psychological coping

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch
Notes
Cancer. - 126, 17 (2020) , 4032-4041, ISSN: 1097-0142

Keyword
Therapietreue
Arzneimittelüberwachung

Event
Veröffentlichung
(where)
Freiburg
(who)
Universität
(when)
2020

DOI
10.1002/cncr.33004
URN
urn:nbn:de:bsz:25-freidok-1669226
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:48 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Time of origin

  • 2020

Other Objects (12)